Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Bictegravir Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 450Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
    FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

    20 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-80375.pdf

    FDA
    20 Nov 2023
    Share Share
    FDA Confirms Para IV Patent Litigation for Bictegravir Sodium, Emtricitabine, Tenofovir Alafenamide Fumarate Tablet
    FDA Confirms Para IV Patent Litigation for Bictegravir Sodium, Emtricitabine, Tenofovir Alafenamide Fumarate Tablet

    06 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-bictegravir-sodium-emtricitabine-tenofovir-alafenamide-fumarate-tablet-1649312230.pdf

    FDA
    06 Apr 2022
    Share Share
    FDA Unveils 34 New and Revised Product-Specific Draft Guidances
    FDA Unveils 34 New and Revised Product-Specific Draft Guidances

    17 May 2019

    // Ana Mulero RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/5/fda-unveils-34-new-and-revised-product-specific-dr

    Ana Mulero RAPS
    17 May 2019
    Share Share
    Singapore HSA Approves Biktarvy for Treatment of HIV-1 Infection
    Singapore HSA Approves Biktarvy for Treatment of HIV-1 Infection

    13 Feb 2019

    // PR NEWSWIRE

    https://en.prnasia.com/releases/apac/singapore-health-sciences-authority-approves-biktarvy-r-bictegravir-emtricitabine-tenofovir-alafenamide-for-treatment-of-hiv-1-infection-237107.shtml

    PR NEWSWIRE
    13 Feb 2019
    Share Share
    GSK looks to oncology for growth as Advair generic hits
    GSK looks to oncology for growth as Advair generic hits

    06 Feb 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/as-advair-generic-hits-gsk-looks-to-oncology-as-new-growth-point-alongside-shingrix-and-hiv

    Angus Liu FIERCE PHARMA
    06 Feb 2019
    Share Share
    Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
    Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV

    22 Jan 2019

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/yale-researchers-discover-protein-in-the-immune-system-can-help-suppress-hiv/

    Alex Keown BIOSPACE
    22 Jan 2019
    Share Share